1 Köhler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497 (1975).

2 Nelson, A.L. & Reichert, J.M. Development trends for therapeutic antibody fragments. Nat. Biotechnol. 27, 331–337 (2009).

3 Bird, R.E. et al. Single-chain antigen-binding proteins. Science 242, 423–426 (1988).

4 Holliger, P. & Hudson, P.J. Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23, 1126–1136 (2005).

5 Aubrey, N. et al. Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI and functional evaluation versus other antibody fragments. Toxicon 43, 233–241 (2004).

6 Eisenhardt, S.U., Schwarz, M., Bassler, N. & Peter, K. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat. Protoc. 2, 3063–3073 (2007).

7 Chapman, A.P. PEGylated antibodies and antibody fragments for improved therapy: a review. Adv. Drug Deliv. Rev. 54, 531–545 (2002).

8 Zahid, M. et al. Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential. Anal. Biochem. 417, 274–282 (2011).

9 Dubreuil, O. et al. Fine tuning of the specificity of an anti-progesterone antibody by first and second sphere residue engineering. J. Biol. Chem. 280, 24880–24887 (2005).

10 Rouet, R. et al. Expression of high-affinity human antibody fragments in bacteria. Nat. Protoc. 7, 364–373 (2012).

11 Muzard, J. et al. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro. FEBS J. 276, 4207–4222 (2009).

12 di Tommaso, A. et al. Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom. J. Biol. Chem. 287, 14149–14156 (2012).

13 Kontermann, R.E. Strategies to extend plasma half-lives of recombinant antibodies. Biodrugs 23, 93–109 (2009).

14 Juste, M., Martin-Eauclaire, M.F., Devaux, C., Billiald, P. & Aubrey, N. Using a recombinant bispecific antibody to block Na+-channel toxins protects against experimental scorpion envenoming. Cell Mol. Life Sci. 64, 206–218 (2007).

15 Aubrey, N. et al. Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin. Cell Mol. Life Sci. 60, 617–628 (2003).

16 Nelson, A.L., Dhimolea, E. & Reichert, J.M. Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discov. 9, 767–774 (2010).

17 Barbas III, C.F., Burton, D.R., Scott, J.K. & Silverman, G.J. Phage Display: A laboratory Manual (Cold Spring Harbor Laboratory Press, 2004).

18 Grimm, S., Yu, F. & Nygren, P.A. Ribosome display selection of a murine IgG(1) Fab binding affibody molecule allowing species selective recovery of monoclonal antibodies. Mol. Biotechnonol. 48, 263–276 (2011).

19 Chao, G. et al. Isolating and engineering human antibodies using yeast surface display. Nat. Protoc. 1, 755–768 (2006).

20 Cotten, S.W., Zou, J., Valencia, C.A. & Liu, R. Selection of proteins with desired properties from natural proteome libraries using mRNA display. Nat. Protoc. 6, 1163–1182 (2011).

21 Mazor, Y., Blarcom, T.V., Iverson, B.L. & Georgiou, G. E-clonal antibodies: selection of full-length IgG antibodies using bacterial periplasmic display. Nat. Protoc. 3, 1766–1777 (2008).

22 Haque, A. & Tonks, K.T. The use of phage display to generate conformation-sensor recombinant antibodies. Nat. Protoc. 7, 2127–2143 (2012).

23 Lee, C.M.Y., Iorno, N., Sierro, F. & Christ, D. Selection of human antibody fragments by phage display. Nat. Protoc. 2, 3001–3008 (2007).

24 O'Connell, D., Becerril, B., Roy-Burman, A., Daws, M. & Marks, J.D. Phage versus phagemid libraries for generation of human monoclonal antibodies. J. Mol. Biol. 321, 49–56 (2002).

25 Bourbeillon, J. et al. Minimum information about a protein affinity reagent (MIAPAR). Nat. Biotechnol. 28, 650–653 (2010).

26 Borrebaeck, C.A.K. Antibody Engineering, 2nd edn. (Oxford University Press, 1994).

27 Gustafsson, C., Govindarajan, S. & Minshull, J. Codon bias and heterologous protein expression. Trends Biotechnol. 22, 346–353 (2004).

28 Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: a Laboratory Manual 3rd edn. (eds. Sambrook, J. & Russell, D.W.) 11.98–11.133 (Cold Spring Harbor Laboratory Press, 2001).

29 Muzard, J., Loyau, S., Ajzenberg, N., Billiald, P. & Jandrot-Perrus, M. Antithrombotic recombinant antibodies. J. Soc. Biol. 200, 365–376 (2006).

30 McGregor, D.P., Molloy, P.E., Cunningham, C. & Harris, W.J. Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. Mol. Immunol. 31, 219–226 (1994).

31 Muzard, J. Recent patent applications in antibody fragments: an academic update from the EU. Nat. Biotechnol. 29, 979 (2011).

32 Muzard, J., Fields, C., O'Mahony, J.J. & Lee, G.U. Probing the soybean Bowman Birk Inhibitor using recombinant antibody fragments. J. Agric. Food Chem. 60, 6164–6172 (2012).

33 Kortt, A.A., Dolezal, O., Power, B.E. & Hudson, P.J. Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting. Biomol. Eng. 18, 95–108 (2001).

34 Muzard, J. et al. Grafting of protein L-binding activity onto recombinant antibody fragments. Anal Biochem. 388, 331–338 (2009).

35 Juste, M., Muzard, J. & Billiald, P. Cloning of the antibody κ light chain V-gene from murine hybridomas by bypassing the aberrant MOPC21-derived transcript. Anal Biochem. 349, 159–161 (2006).

36 Heo, M.A. et al. Functional expression of single-chain variable fragment antibody against c-Met in the cytoplasm of Escherichia coli. Protein Expr. Purif. 47, 203–209 (2006).

37 Tolner, B., Smith, L., Begent, R.H.J. & Chester, K.A. Production of recombinant protein in Pichia pastoris by fermentation. Nat. Protoc. 1, 1006–1021 (2006).

38 Hardiman, G. Next-generation antibody discovery platforms. Proc. Natl Acad. Sci. USA 109, 1824–1826 (2012).

39 Kabat, E.A., Wu, T.T., Perry, H., Gottesman, G. & Foeller, C. Sequences of Proteins of Immunological Interest 5th edn. US Department of Health and Human Services, Public Health Service, National Institutes of Health (NIH): NIH publication no. 91-3242 (1991).

40 Hornig, N. & Färber-Schwarz, A. Production of bispecific antibodies: diabodies and tandem scFv. Methods Mol. Biol. 907, 713–727 (2012).

41 Ruberti, F., Cattaneo, A. & Bradbury, A. The use of the RACE method to clone hybridoma cDNA when V region primers fail. J. Immunol. Methods 173, 33–39 (1994).

42 Kaas, Q. & Lefranc, M.P. IMGT Colliers de Perles: standardized sequence-structure representations of the IgSF and MhcSF superfamily domains. Curr. Bioinformatics 2, 21–30 (2007).

43 Kaas, Q., Ehrenmanns, F. & Lefranc, M.P. IG, TR, MHC, IgSf and MhcSF: what do we learn from the IMGT Colliers de Perles? Brief. Funct. Genomic Proteomic. 6, 253–264 (2007).

44 Honegger, A. & Plückthun, A. Yet another numbering scheme for immunoglobulin variable domains: An automatic modeling and analysis tool. J. Mol. Biol. 309, 657–670 (2001).

45 Billiald, P., Motta, G. & Vaux, D.J. Production of a functional anti-scorpion hemocyanin scFv in Escherichia coli. Arch. Biochem. Biophys. 317, 429–438 (1995).

46 Zhou, H., Fisher, R.J. & Papas, T.S. Optimization of primer sequences for mouse scFv repertoire display library construction. Nucleic Acids Res. 22, 888–889 (1994).

47 Ortega, C. et al. High level prokaryotic expression of anti-Müllerian inhibiting substance type II receptor diabody, a new recombinant antibody for in vivo ovarian cancer imaging. J. Immunol. Methods 387, 11–20 (2013).

48 Schaefer, J.V. & Plückthun, A. Improving expression of scFv fragments by co-expression of periplasmic chaperones. in Antibody Engineering 2nd edn. (eds. Kontermann, R. & Dübel, S.) 2, 345–361 (Springer, 2010).

49 Vincze, T., Posfai, J. & Roberts, R.J. NEBcutter: a program to cleave DNA with restriction enzymes. Nucleic Acids Res. 31, 3688–3691 (2003).

50 Ehrenmann, F., Giudicelli, V., Duroux, P. & Lefranc, M.P. IMGT/Collier de Perles: IMGT standardized representation of domains (IG, TR, and IgSF variable and constant domains, MH and MhSF groove domains). Cold Spring Harbor Protoc. 6, 726–736 (2011).

51 Martin, A.C.R. Accessing the Kabat antibody sequence database by computer PROTEINS: Structure, Function and Genetics. Proteins 25, 130–133 (1996).

52 Whitelegg, N.R.J. & Rees, A.R. WAM: an improved algorithm for modeling antibodies on the web. Protein Eng. 13, 819–824 (2000).

53 Bruccoleri, R.E. Application of systematic conformational search to protein modelling. Mol. Simul. 10, 151–174 (1993).

54 Sivasubramanian, A., Sircar, A., Chaudhury, S. & Gray, J.J. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins 74, 497–514 (2009).

55 Duhovny, D., Nussinov, R. & Wolfson, H.J. Efficient unbound docking of rigid molecules. in Proceedings of the 2nd Workshop on Algorithms in Bioinformatics (WABI), Rome, Italy; Lecture Notes in Computer Science (ed. Gusfield et al.) 2452, 185–200 (Springer, 2002).